Carbohydrates are essential mediators of many processes in health and disease. They
regulate self-/non-self-discrimination, are key elements of cellular communication, cancer …

The complex pathogenesis of inflammatory bowel disease (IBD) explains the several
hurdles for finding an efficient approach to cure it. Nowadays, therapeutic protocols aim to …

Background Antimicrobials are often used to prevent and treat diarrhea induced by
enteroaggregative Escherichia coli (EAEC) in young ruminants. However, drug overuse or …

The gut microbiota plays a significant role in the pathogenesis of both forms of inflammatory
bowel disease (IBD), namely Crohn's disease (CD) and ulcerative colitis (UC). While …

The surge in inflammatory bowel diseases, like Crohn's disease (CD), is alarming. While the
role of the gut microbiome in CD development is unresolved, the frequent isolation of …

Escherichia coli K99 (E. coli K99) is one of the important pathogenic bacteria in calf
production causing massive loss every year, and Lactobacillus acidophilus (L. acidophilus) …

The FimH type-1 fimbrial adhesin allows pathogenic Escherichia coli to adhere to
glycoproteins in the epithelial linings of human bladder and intestinal tract, by using multiple …

Anti-Saccharomyces cerevisiae antibodies (ASCA) are human antibodies that can be
detected using an enzyme-linked immunosorbent assay involving a mannose polymer …

Inflammatory bowel disease (IBD) is a multifactorial intractable intestinal disease. Focusing
on only one facet of the pathogenesis of IBD is insufficient to fully capture the complexity of …

Enrichment of adherent-invasive Escherichia coli (AIEC) has been consistently detected in
subsets of inflammatory bowel disease (IBD) patients. Although some AIEC strains cause …